Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Artesunate intravenous - US Army Medical Material Development Activity/Walter Reed Army Institute of Research

Next Previous
Search
Drug Profile

Artesunate intravenous - US Army Medical Material Development Activity/Walter Reed Army Institute of Research

Alternative Names: Artesunate intravenous project - MMV00/1013; Artesunate IV; Artesunate IV project - MMV00/1013; Intravenous artesunate; IV artesunate; Nuartez

Latest Information Update: 21 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator U.S. Army Medical Materiel Development Activity; Walter Reed Army Institute of Research
  • Developer Amivas; U.S. Army Medical Material Development Activity; Walter Reed Army Institute of Research
  • Class 3-ring heterocyclic compounds; Antimalarials; Artemisinins; Small molecules; Succinates
  • Mechanism of Action Reactive oxygen species stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malaria
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Malaria

Most Recent Events

  • 28 Feb 2025 Amivas plans a phase II trial for Cytomegalovirus infections treatment (Combination therapy) in May 2025 (IV) (NCT06853184)
  • 17 Oct 2024 Launched for Malaria (In adults, In children) in Denmark, Finland, Sweden (IV),
  • 17 Oct 2024 Launched for Malaria (In adults, In children) in Norway (IV),

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top